Sigma1 receptor antagonist BD1047 enhances reversal of conditioned place preference from cocaine to social interaction

Pharmacology. 2011;87(1-2):45-8. doi: 10.1159/000322534. Epub 2010 Dec 29.

Abstract

We have previously shown that only four 15-min social interaction episodes with a male adult conspecific reversed cocaine conditioned place preference (CPP) even despite continuing CPP training with cocaine. In the present study, we investigated if BD1047, a sigma1 receptor antagonist that has been shown to inhibit the expression of cocaine CPP, is able to enhance this effect. BD1047, given as a 10-min pretreatment, dose-dependently (ED50 of 0.0036 mg/kg i.p.) decreased the time spent in the previously cocaine-associated compartment in favour of the time spent in the compartment in which a single social interaction had taken place. Our findings indicate that sigma1 blockade may be used therapeutically to enhance treatment adherence in social interaction-based rehabilitation programs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal / drug effects*
  • Cocaine / antagonists & inhibitors*
  • Cocaine / pharmacology
  • Cocaine-Related Disorders / drug therapy*
  • Cocaine-Related Disorders / therapy
  • Combined Modality Therapy
  • Conditioning, Operant / drug effects*
  • Dopamine Uptake Inhibitors / antagonists & inhibitors
  • Dopamine Uptake Inhibitors / pharmacology
  • Dose-Response Relationship, Drug
  • Ethylenediamines / therapeutic use*
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, sigma / antagonists & inhibitors*
  • Sigma-1 Receptor
  • Social Behavior*

Substances

  • Dopamine Uptake Inhibitors
  • Ethylenediamines
  • Receptors, sigma
  • N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin
  • Cocaine